跳至主要内容
临床试验/NCT04628416
NCT04628416招募中不适用

Evaluation of the PICO® Negative Pressure Dressing System on the Fibula Free Flap Donor Site's Skin Graft.

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2021年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
112
试验地点
1
主要终点
The percentage of failure of skin grafting (surface on which the skin graft did not take)

研究概览

简要总结

A fibula free flap can be used for the reconstruction of a mandible or a maxillar when the lack of bonne exceeds 3cm. This flap is made of the fibula bone, some muscle around, the fibular vascular pedicle and a skin paddle to reconstruct the gum. Once this flap has been taken and transposed on the face, the leg is closed with a split thickness skin graft to replace the skin paddle. But the healing on this site is often a problem: this is partly due to the high rate of early graft's loss due to local devascularization (3 to 55% of loss). The skin grafting is generally improved by the application of a dressing sewn and left in place during 5 to 7 days postoperative (standard method). This study will evaluate the efficiency of a portative miniature negative pressure dressing system named PICO® on the split-thickness skin graft of fibula free flap donor sites, compared to the standard method. A prospective randomized evaluation will be done, comparing the PICO® to a conventional dressing. The main aim of the study is the evaluation of the impact of this portative system on the healing of the skin grafted donor site, in terms of rate of skin take, time of healing, complications and medical costs. The patients will be seen preoperatively to decide on their inclusion in the protocol. They will be reviewed at day 10 to evaluate the engraftment and possible local complications on the donor site. They will then be reviewed at day 20 and day 30 and until complete healing. The follow up will be of 12 months maximum. A medical cost evaluation will be done comparing the costs generated by the care on the donor site in the 2 groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years old
  • Any patient requiring a fibula free flap with skin paddle
  • Theoretical need of a skin graft for the closure of the donor site (evaluated by the surgeon in charge of the patient at the time of inclusion) and performed at the same time as the fibula flap
  • Signature of informed consent.

排除标准

  • Contraindication to making a fibula free flap:
  • anesthetic contraindication,
  • atheroma in the leg arteries obstructing more than 60% of the arterial lumen (objectified by CT angiography of lower limbs)
  • Contraindication to the setting up of a negative pressure therapy:
  • allergy to one of the PICO® components
  • infection in the donor area
  • cutaneous lesions of the lower limb preventing the placement of an occlusive dressing or making it impossible to seal the device
  • No affiliation to a social security scheme.
  • Minor or major patients who are protected or unable to give their consent (according to article L1121-8 of the Public Health Code (PHC))
  • Pregnant or lactating women (according to article L1121-5 of the PHC)
  • Vulnerable people (according to article L1121-6 of the PHC)

结局指标

主要结局

The percentage of failure of skin grafting (surface on which the skin graft did not take)

时间窗: on Day 10 postoperative (+/- 2 days)

次要结局

  • Tendon exposure rate evaluated at day 10 (+/- 2 days) and day 20 (+/- 2 days) by the surgeon during hospitalization or in consultation if the patient is discharged.(Day 10 (+/- 2 days) and day 20 (+/- 2 days))
  • Rate of patients for whom during of hospitalization was lengthened exclusively due to a problem with the skin graft. (Duration of hospitalization)(At 12 months)
  • Evaluation of patient discomfort related to the PICO® device or to the standard dressing (noise, bulk, dressing) during the first 7 postoperative days. This discomfort is measured by an EVA of 0 to 100 measuring the discomfort experienced.(day 10)
  • Rate of other surgery due to a problem on the skin grafted area.(Through complete healing, a maximum of 1 year)
  • Treatment tolerance evaluation, measured wtih rate of adverse reaction(Day 20)
  • Cost-effectiveness ratio. The medical and non-medical costs will be collect on the case report form(At 12 months)
  • Rate of infection of the grafted site at day 10 (+/- 2 days) and day 20 (+/- 2 days), evaluated by the surgeon during hospitalization or in consultation if the patient is discharged(Day 10 (+/- 2 days) and day 20 (+/- 2 days))
  • Delay between the day of the operation and the complete healing of the donor site of the fibula flap (in days)(Through complete healing, a maximum of 1 year)
  • Evolution of the quality of life at 1 month postoperative (+/- 4 days) compared to preoperative (assessed by the Short Form-12 Health Survey Version 2 (SF-12v2))(At 1 month after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验